Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) EBITDA (2018 - 2023)

Historic EBITDA for ImmunoTech (AIM) over the last 6 years, with Q4 2023 value amounting to -$14.0 million.

  • ImmunoTech's EBITDA changed N/A to -$14.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$28.8 million, marking a year-over-year change of. This contributed to the annual value of -$19.8 million for FY2024, which is 3804.99% up from last year.
  • ImmunoTech's EBITDA amounted to -$14.0 million in Q4 2023.
  • ImmunoTech's EBITDA's 5-year high stood at -$3.3 million during Q2 2020, with a 5-year trough of -$14.0 million in Q4 2023.